Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1801170/000119312521102551/d89571d10k.htm
May 2024
April 2024
April 2024
April 2024
March 2024
January 2024
December 2023
December 2023
December 2023
November 2023
Exhibit 99.1
Clover Health Reports Full Year 2020 Financial Results
Grew total revenue 46% year-over-year to $673 million in 2020
Surpassed 32,400 Lives under Clover Assistant management at year end, a 43% increase year-over-year
NASHVILLE, Tenn., -- Clover Health (Nasdaq: CLOV)(Clover), an innovative technology company improving health outcomes for Americas seniors, today reported financial results for the fourth quarter and full year of 2020. Management will host a conference call today at 5:00 p.m. ET to discuss its operating results and other business highlights. Supplemental management commentary can be found by accessing the Companys shareholder letter posted on its investor relations website at https://investors.cloverhealth.com/.
2020 was a difficult year for healthcare as our industry rose to the numerous challenges posed by the pandemic. Nevertheless, it was also a transformative year for Clover. By year end we had more than 58,000 members, reported over $670 million in total revenue and created our Direct Contracting entity, Clover Health Partners. We believe Clover is perfectly positioned to be the pioneer of the new program, said Clover Health CEO Vivek Garipalli. We built the Clover Assistant to reduce variability in physician decision making and enhance our members lives. As of year end, approximately 32,400 members, or 56% of total membership, were managed by a PCP that was live on the Clover Assistant. This represents a 43% increase year-over-year, underpinned by our ability to expand coverage. We believe the traction we have seen to date demonstrates the value of the Clover Assistant, giving us conviction in our ability to scale our platform through both Medicare Advantage and Direct Contracting. Clover Health is well-positioned to leverage technology to improve patient care and deliver value for all of our stakeholders, concluded Garipalli.
Andrew Toy, President and CTO of Clover Health added, Clover is bringing free enterprise-grade technology to patient care, something that has never been done before. Our technology-first business model is disrupting an industry that has been slow to embrace technology advancements. The newest go-to-market strategy for the Clover Assistant, Direct Contracting, should provide us with a faster and simpler way to increase the number of lives on our platform, and drive value for consumers and physicians. We look forward to the official launch of Direct Contracting in April, which we believe will drive further proliferation of the Clover Assistant as we execute on our mission to improve every life.
As previously announced, on January 7, 2021, Clover Health and Social Capital Hedosophia III (SCH) completed their merger (the Merger). Immediately following the Merger, SCH changed its name to Clover Health and its Class A common stock and warrants to purchase Class A common stock began trading on the Nasdaq Global Select Market (Nasdaq) under the symbols CLOV and CLOVW, respectively.
1
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1801170/000119312521102551/d89571d10k.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Clover Health Investments, Corp. De.
Clover Health Investments, Corp. De's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Clover Health Investments, Corp. De provided additional information to their SEC Filing as exhibits
Ticker: CLOV
CIK: 1801170
Form Type: 10-K Annual Report
Accession Number: 0001193125-21-102551
Submitted to the SEC: Wed Mar 31 2021 5:25:49 PM EST
Accepted by the SEC: Wed Mar 31 2021
Period: Thursday, December 31, 2020
Industry: Hospital And Medical Service Plans